WHO-led coalition needs $31.3 billion to fight COVID-19 pandemic. The money would go to the Access to COVID-19 Tools Accelerator, or ACT-Accelerator, a global collaboration initiated in April to accelerate development.
Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.
‘COVID-19: We have over 200 vaccine candidates at some stage of clinical development, 15 of them are now on human clinical trials," said WHO Chief Scientist Soumya Swaminathan.’
j in a funding gap of $27.9 billion, of which $13.7 billion of the remaining gap is urgently needed. It plans to scale up delivery of 500 million tests and 245 million courses of treatments to low- and middle-income countries (LMICs) by mid-2021, as well as two billion vaccine doses, of which one billion to be purchased for LMICs, by the end of 2021. "The investment required is significant, but it pales in significance when compared to the cost of COVID-19," said WHO in a statement, adding that the total cost of the ACT-Accelerator's work is less than a tenth of what the International Monetary Fund estimates the global economy is losing every month due to the pandemic.
The ACT-Accelerator is led by the work of WHO's partner organizations collaborating under four pillars, including diagnostics, therapeutics, vaccines and the health systems connector. The vaccine pillar, with the combination of the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance, has the estimate that it will cost up to 18.1 billion dollars to deliver two billion doses by the end of 2021. In addition, 950 million doses will need to be procured by self-financing high-income countries and upper middle-income countries.
Indian Namaste the Preferred Greeting over Conventional Handshake
COVID-19 pandemic is causing changes in how we greet each other. The traditional Indian way of greeting with folded hands (Namaste) is now being preferred over handshake. Namaste has more to it than just being a greetings, read to find out
COVID-19 pandemic is causing changes in how we greet each other. The traditional Indian way of greeting with folded hands (Namaste) is now being preferred over handshake. Namaste has more to it than just being a greetings, read to find out
Source-IANS
Lung Care Before and After COVID-19
COVID-19 infection causes persistent symptoms such as difficulty breathing and weakness even after being discharged from hospitals. Such people should focus on healthy nutrition and deep breathing exercises to prevent secondary lung infections.
COVID-19 infection causes persistent symptoms such as difficulty breathing and weakness even after being discharged from hospitals. Such people should focus on healthy nutrition and deep breathing exercises to prevent secondary lung infections.
Post-COVID-19 Inflammatory Syndrome Seen in Children
Children suffering from multisystem hyperinflammatory response post-COVID-19 have a variety of symptoms, including fever, headaches, abdominal pain, rash and conjunctivitis. In severe cases, inflammation in the walls of the blood vessels occurs, leading to toxic shock syndrome.
Children suffering from multisystem hyperinflammatory response post-COVID-19 have a variety of symptoms, including fever, headaches, abdominal pain, rash and conjunctivitis. In severe cases, inflammation in the walls of the blood vessels occurs, leading to toxic shock syndrome.
